Effects of combined estrogen and bazedoxifene (CEB) on depressive symptoms in perimenopause.

Bondy E, Prim J, Rubinow D, Schiff L, Dichter GS, Schiller CE

Open source

DOI
10.1016/j.jad.2025.119853
Published
2025 Dec 1
Container
Journal of affective disorders
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jad.2025.119853,
  title = {Effects of combined estrogen and bazedoxifene (CEB) on depressive symptoms in perimenopause.},
  author = {Bondy E and Prim J and Rubinow D and Schiff L and Dichter GS and Schiller CE},
  year = {2025},
  journal = {Journal of affective disorders},
  doi = {10.1016/j.jad.2025.119853},
  url = {https://doi.org/10.1016/j.jad.2025.119853}
}

RIS

TY  - JOUR
TI  - Effects of combined estrogen and bazedoxifene (CEB) on depressive symptoms in perimenopause.
AU  - Bondy E
AU  - Prim J
AU  - Rubinow D
AU  - Schiff L
AU  - Dichter GS
AU  - Schiller CE
PY  - 2025
JO  - Journal of affective disorders
DO  - 10.1016/j.jad.2025.119853
UR  - https://doi.org/10.1016/j.jad.2025.119853
ER  - 

APA

E, B., J, P., D, R., L, S., GS, D., & CE, S. (2025). Effects of combined estrogen and bazedoxifene (CEB) on depressive symptoms in perimenopause.. Journal of affective disorders. https://doi.org/10.1016/j.jad.2025.119853

Source records